| Copper | Approved Investigational | BTN3A2 | 11118 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of BTN3A2 mRNA | 6p22.2 | |
| Copper | Approved Investigational | BUB1B | 701 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of BUB1B mRNA | 15q15.1 | |
| Copper | Approved Investigational | C1R | 715 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of C1R mRNA | 12p13.31 | |
| Copper | Approved Investigational | C1S | 716 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of C1S mRNA | 12p13.31 | |
| Copper | Approved Investigational | C1S | 716 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of C1S mRNA | 12p13.31 | |
| Copper | Approved Investigational | C5 | 727 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of C5 mRNA | 9q33.2 | |
| Copper | Approved Investigational | CA2 | 760 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CA2 mRNA | 8q21.2 | |
| Copper | Approved Investigational | CA7 | 766 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CA7 mRNA | 16q22.1 | |
| Copper | Approved Investigational | CABLES1 | 91768 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CABLES1 mRNA | 18q11.2 | |
| Copper | Approved Investigational | CACHD1 | 57685 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CACHD1 mRNA | 1p31.3 | |
| Copper | Approved Investigational | CACNA1A | 773 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CACNA1A mRNA | 19p13.13 | |
| Copper | Approved Investigational | CACYBP | 27101 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CACYBP mRNA | 1q25.1 | |
| Copper | Approved Investigational | CACYBP | 27101 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CACYBP mRNA | 1q25.1 | |
| Copper | Approved Investigational | CADPS2 | 93664 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CADPS2 mRNA | 7q31.32 | |
| Copper | Approved Investigational | CALCA | 796 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CALCA mRNA | 11p15.2 | |
| Copper | Approved Investigational | CALCB | 797 |
downregulated | [Disulfiram binds to Copper] which results in decreased expression of CALCB mRNA | 11p15.2 | |
| Copper | Approved Investigational | CALD1 | 800 |
upregulated | [Disulfiram binds to Copper] which results in increased expression of CALD1 mRNA | 7q33 | |
| Copper | Approved Investigational | CALML4 | 91860 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CALML4 mRNA | 15q23 | |
| Copper | Approved Investigational | CARD6 | 84674 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CARD6 mRNA | 5p13.1 | |
| Copper | Approved Investigational | CARD8 | 22900 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CARD8 mRNA | 19q13.33 | |
| Copper | Approved Investigational | CASP4 | 837 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CASP4 mRNA | 11q22.3 | |
| Copper | Approved Investigational | CBLB | 868 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CBLB mRNA | 3q13.11 | |
| Copper | Approved Investigational | CBX2 | 84733 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CBX2 mRNA | 17q25.3 | |
| Copper | Approved Investigational | CBX5 | 23468 |
downregulated | [NSC 689534 binds to Copper] which results in decreased expression of CBX5 mRNA | 12q13.13 | |
| Copper | Approved Investigational | CCDC126 | 90693 |
upregulated | [NSC 689534 binds to Copper] which results in increased expression of CCDC126 mRNA | 7p15.3 | |